Page 503 - IJB-10-6

International Journal of Bioprinting Nanomaterial-bioinks for DLP bioprinting

89. Montelongo SA, Chiou G, Ong JL, Bizios R, Guda T. 100. Ma H, Feng C, Chang J, Wu C. 3D-printed bioceramic
Development of bioinks for 3D printing microporous, scaffolds: from bone tissue engineering to tumor therapy.
sintered calcium phosphate scaffolds. J Mater Sci Mater Med. Acta Biomaterialia. 2018;79:37-59.
2021;32(8):94. doi: 10.1016/j.actbio.2018.08.026
doi: 10.1007/s10856-021-06569-9
101. Wu M, Zou L, Jiang L, Zhao Z, Liu J. Osteoinductive and
90. Fischetti T, Borciani G, Avnet S, et al. Incorporation/ antimicrobial mechanisms of graphene-based materials for
enrichment of 3D bioprinted constructs by biomimetic enhancing bone tissue engineering. J Tissue Eng Regen Med.
nanoparticles: tuning printability and cell behavior in bone 2021;15(11):915-935.
models. Nanomaterials (Basel). 2023;13(14):2040. doi: 10.1002/term.3239
doi: 10.3390/nano13142040
102. Shin SR, Li YC, Jang HL, et al. Graphene-based materials
91. Raghav PK, Mann Z, Ahlawat S, Mohanty S. Mesenchymal for tissue engineering. Adv Drug Deliv Rev. 2016;
stem cell-based nanoparticles and scaffolds in regenerative 105(Pt B):255-274.
medicine. Eur J Pharmacol. 2022;918:174657. doi: 10.1016/j.addr.2016.03.007
doi: 10.1016/j.ejphar.2021.174657
103. Farshid B, Lalwani G, Mohammadi MS, et al. Two-
92. Cernencu AI, Vlasceanu GM, Serafim A, Pircalabioru dimensional graphene oxide-reinforced porous
G, Ionita M. 3D double-reinforced graphene oxide –
nanocellulose biomaterial inks for tissue engineered biodegradable polymeric nanocomposites for bone tissue
constructs. RSC Adv. 2023;13(34):24053-24063. engineering. J Biomed Mater Res A. 2019;107(6):1143-1153.
doi: 10.1039/D3RA02786D doi: 10.1002/jbm.a.36606
93. Steward AJ, Kelly DJ. Mechanical regulation of mesenchymal 104. Catoira MC, Fusaro L, Di Francesco D, Ramella M,
stem cell differentiation. J Anat. 2015;227(6):717-731. Boccafoschi F. Overview of natural hydrogels for
doi: 10.1111/joa.12243 regenerative medicine applications. J Mater Sci Mater Med.
2019;30(10):115.
94. Phinney DG. Functional heterogeneity of mesenchymal doi: 10.1007/s10856-019-6318-7
stem cells: implications for cell therapy. J Cell Biochem.
2012;113(9):2806-2812. 105. Zhou L, Tan G, Tan Y, Wang H, Liao J, Ning C. Biomimetic
doi: 10.1002/jcb.24166 mineralization of anionic gelatin hydrogels: Effect of degree
of methacrylation. RSC Adv. 2014;4:21997.
95. Costa LA, Eiro N, Fraile M, et al. Functional heterogeneity doi: 10.1039/c4ra02271h
of mesenchymal stem cells from natural niches to culture
conditions: implications for further clinical uses. Cell Mol 106. Castillo Diaz LA, Saiani A, Gough JE, Miller AF.
Life Sci. 2021;78(2):447-467. Human osteoblasts within soft peptide hydrogels
doi: 10.1007/s00018-020-03600-0 promote mineralisation in vitro. J Tissue Eng.
2014;5:2041731414539344.
96. Talukdar Y, Rashkow J, Lalwani G, Kanakia S, Sitharaman
B. The effects of graphene nanostructures on mesenchymal doi: 10.1177/2041731414539344
stem cells. Biomaterials. 2014;35(18):4863-4877. 107. Gerhardt LC, Boccaccini AR. Bioactive glass and glass-
doi: 10.1016/j.biomaterials.2014.02.054 ceramic scaffolds for bone tissue engineering. Materials.
97. Golub EE, Boesze-Battaglia K. The role of alkaline phosphatase 2010;3(7):3867-3910.
in mineralization. Curr Opin Orthopaed. 2007;18(5):444-448. doi: 10.3390/ma3073867
doi: 10.1097/BCO.0b013e3282630851 108. Morgan EF, Unnikrisnan GU, Hussein AI. Bone mechanical
98. Sharma U, Pal D, Prasad R. Alkaline phosphatase: an properties in healthy and diseased states. Annu Rev Biomed
overview. Indian J Clin Biochem. 2014;29(3):269-278. Eng. 2018;20(2018):119-143.
doi: 10.1007/s12291-013-0408-y doi: 10.1146/annurev-bioeng-062117-121139
99. Rutkovskiy A, Stensløkken KO, Vaage IJ. Osteoblast 109. Diaz-Rodriguez P, Sánchez M, Landin M. Drug-loaded
differentiation at a glance. Med Sci Monit Basic Res. biomimetic ceramics for tissue engineering. Pharmaceutics.
2016;22:95-106. 2018;10(4):272.
doi: 10.12659/msmbr.901142 doi: 10.3390/pharmaceutics10040272

Volume 10 Issue 6 (2024) 495 doi: 10.36922/ijb.4015